Let's Connect

News

Ketamine drugmakers seek FDA approval as providers raise concerns: 5 things to know

By Ella Ruder 1 min read

More than a dozen companies are racing to win FDA approval for ketamine-based mental health treatments. Providers warn that one company’s bid could sharply raise the cost of the generic drug, while most of the new products are designed to skip the talk therapy many clinicians consider essential, The New York Times reported Oct. 20. The companies are developing new formulations and combinations of ketamine, a generic anesthetic increasingly used off-label for depression and other mental health conditions. Johnson & Johnson’s Spravato, a ketamine-like nasal spray, is the only FDA-approved… Originally published in Becker’s Hospital Review. Read More

Share this post
All News posts
News Ella Ruder 10:00 am Children’s Hospital Colorado to open mental health emergency unit Aurora-based Children’s Hospital Colorado is adding a pediatric mental health emergency unit and crisis stabilization services at its South Campus in Highlands Ranch, Colo., funded in part by $3.4 million in Douglas County opioid settlement dollars. Douglas County commissioners joined hospital leaders, donors and community… News Ella Ruder 9:32 am Huntsman Mental Health Foundation receives $35M gift for new research building Salt Lake City-based Huntsman Mental Health Foundation received a $35 million gift from Gail Miller and the Larry H. & Gail Miller Family Foundation to support a new translational research building at Huntsman Mental Health Institute at the University of Utah. The foundation said Nov.… News Ella Ruder 8:56 am The 7 states that ban AI therapy chatbots Seven states now ban AI therapy chatbots, and Pennsylvania’s medical board has taken a chatbot developer to court in what the Petrie-Flom Center at Harvard Law School in Cambridge, Mass., said appears to be the first such case under a medical practice act, according to…

Integrated Psychiatric Consultants

Office Hours:
Mon-Fri, 9 a.m. - 5 p.m. CT

Follow us

Reach out today.

Integrated Psychiatric Consultants (IPC) is committed to protecting and respecting your privacy. Our team will use the information collected here solely to serve your needs and notify you about relevant services. To consent, please check the box above and submit this form.

Please note, this consent applies to all forms of communications, including SMS. If you have provided a mobile phone number above, you agree to receiving SMS messages from IPC. You may unsubscribe at any time. Message frequency varies. Messaging and data rates may apply. Reply STOP to cancel. For more information, please review our Privacy Policy.